Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Source: Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status
Download Slideset
Review the latest evidence on HER2 testing, clinical implications of HER2-low status in advanced breast cancer, and mastering the safety profile of antibody-drug conjugates, including current guidelines and expert’s recommendations.
person default
Nadia Harbeck, MD, PhD
Komal Jhaveri, MD
Heather McArthur, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 2.45 MB
Released: December 8, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca Pharmaceuticals
Daiichi Sankyo, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings